
This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found on the website by clicking on the sponsors tab.

Hannah Beba
Consultant Pharmacist, West Yorkshire Health & Care Partnership

Heather Bell
GP Principal, Carrickfergus

Pam Brown
GP, Swansea

Dr Eimear Darcy
GP Partner, GPwSpI Obesity/Cardio Metabolic Review, Grange Family Practice, NI

Lesley Hamilton
Diabetes Dietitian Specialist and Diabetes Network Manager, Western Trust

Itunu Johnson-Sogbetun
General Practitioner with a specialist interest in women’s health and menopause care
Glynis Magee
Consultant Community Endocrinologist

Prof Tunde Peto
Professor of Clinical Ophthalmology

Edward McKeever
Consultant Endocrinologist, Western Health and Social Care Trust

Katie Speers
Diabetes Specialist Nurse

Supporting the NHS to deliver sustainable healthcare solutions
At Daiichi Sankyo UK, we create and supply innovative products to help the NHS to deliver better patient care in the fields of cardiovascular disease and oncology.
Our mission is to contribute to the enrichment of quality of life through the discovery and delivery of innovative medicines that address diverse and unmet medical needs.
We strive to provide solutions to support high-quality and sustainable healthcare, including for the NHS dispensing surgery community.
For more information about Daiichi Sankyo visit https://www.daiichi-sankyo.co.uk

Lilly is a medicine company turning science into therapies to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world's most significant health challenges.
We've been a global leader in diabetes since 1923, and through our research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.
To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.




This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found on the website by clicking on the sponsors tab.